Federal contract award
75F40124F19002
2-YEAR, FIRM FIXED PRICE (FFP) TYPE TASK ORDER TO PROCURE COMPARATIVE USE HUMAN FACTORS STUDIES TO ASSESS THE IMPACT OF DIFFERENCES BETWEEN THE USER INTERFACES OF A GENERIC DRUG-DEVICE COMBINATION PRODUCT AND ITS REFERENCE LISTED DRUG (CUHF) TO SUPPO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541720 — Research and Development in the Social Sciences and Humanities |
| PSC | B599 — Other Special Studies and Analysis |
| Parent award / vehicle | 75F40123D00028 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $501.8K |
| Current contract value | $501.8K |
| Potential contract value / ceiling | $711.8K |
| Start date | Sep 18, 2024 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Dec 10, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 10, 2025 | P00002 | $0 | CORRECTION MODIFICATION. 2-YEAR, FIRM FIXED PRICE (FFP) TYPE TASK ORDER TO PROCURE COMPARATIVE USE HUMAN FACTORS STUDIES TO ASSESS THE IMPACT OF DIFFERENCES BETWEEN THE USER INTERFACES OF A GENERIC DRUG-DEVICE COMBINATION PRODUCT AND ITS REFERENCE L |
| Aug 13, 2025 | P00001 | $307.1K | 2-YEAR, FIRM FIXED PRICE (FFP) TYPE TASK ORDER TO PROCURE COMPARATIVE USE HUMAN FACTORS STUDIES TO ASSESS THE IMPACT OF DIFFERENCES BETWEEN THE USER INTERFACES OF A GENERIC DRUG-DEVICE COMBINATION PRODUCT AND ITS REFERENCE LISTED DRUG (CUHF) TO SUPPO |
| Sep 18, 2024 | 0 | $194.7K | 2-YEAR, FIRM FIXED PRICE (FFP) TYPE TASK ORDER TO PROCURE COMPARATIVE USE HUMAN FACTORS STUDIES TO ASSESS THE IMPACT OF DIFFERENCES BETWEEN THE USER INTERFACES OF A GENERIC DRUG-DEVICE COMBINATION PRODUCT AND ITS REFERENCE LISTED DRUG (CUHF) TO SUPPO |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.